Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-971-2 | CAS number: 5580-58-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study, compliant with OECD guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted 21st July, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- dated May 30, 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- BSL Bioservice Scientific Laboratories GmbH, Planegg, Germany
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 3,3'-[(2,5-dichloro-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(5-chloro-o-tolyl)benzamide]
- EC Number:
- 226-971-2
- EC Name:
- 3,3'-[(2,5-dichloro-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(5-chloro-o-tolyl)benzamide]
- Cas Number:
- 5580-58-5
- Molecular formula:
- C42H32Cl6N8O6
- IUPAC Name:
- 4-chloro-N-(5-chloro-2-methylphenyl)-3-[(E)-2-{1-[(2,5-dichloro-4-{2-[(E)-2-{2-chloro-5-[(5-chloro-2-methylphenyl)carbamoyl]phenyl}diazen-1-yl]-3-oxobutanamido}phenyl)carbamoyl]-2-oxopropyl}diazen-1-yl]benzamide
- Test material form:
- solid: particulate/powder
Constituent 1
Method
- Target gene:
- his and trp operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Mammalian microsome enzyme activation mixture (supplemented S9 fraction from liver of untreated hamster and from liver of rats induced with phenobarbital and beta-naphthoflavone)
- Test concentrations with justification for top dose:
- 3.16, 10, 31.6, 100, 316, 1000, 2500 and 5000 µg/plate
- Vehicle / solvent:
- The test item was suspended in DMSO and diluted prior to treatment. The solvent was compatible with the survival of the bacteria and the S9 activity.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Remarks:
- A. dest.
- Positive controls:
- yes
- Positive control substance:
- other: Sodium azide (TA 100, TA 1535), 4-nitro-o-phenylene-diamine (4-NOPD; TA 98, TA 1537), Methyl methane sulfonate (MMS; E. coli)
- Remarks:
- without metabolic activation
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene (all strains)
- Remarks:
- with metabolic activation (rat liver)
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene (2-AA; TA 1535, TA 1537, E. coli), Congo Red (TA 98, TA100)
- Remarks:
- with metabolic activation (hamster liver)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) (experiment I); preincubation (experiment II)
DURATION
- Preincubation period: 30 minutes at 30°C
- Exposure duration: at least 48 hours at 37°C
NUMBER OF REPLICATIONS: three plates
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- Evaluation of Cytotoxicity
Cytotoxicity can be detected by a clearing or rather diminution of them background lawn or a reduction in the number of revertants down to a mutation factor of approximately < 0.5 in relation to the solvent control.
Evaluation of Mutagenicity
The Mutation Factor is calculated by dividing the mean value of the revertant counts through the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and E. coli WP2 uvrA the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher
as compared to the reversion rate of the solvent control.
A test item producing neither a dose related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups is considered to be non-mutagenic in this system.
A test is considered acceptable if for each strain:
-the bacteria demonstrate their typical responses to ampicillin (TA 98, TA 100)
- the control plates without S9 mix are within the following ranges (mean values of the spontaneous reversion frequency are within the historical control data range (TA98: 16-46, TA 100: 77-174, TA 1535: 5 -29, TA 1537: 5 -28, E. coli WP2 uvrA: 36-81)
- corresponding background growth on both negative control aod test plates is observed.
- the positive controls show a distinct enhancement of revertant rates over the control plate - Statistics:
- According to the OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
Results and discussion
Test results
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- except in tester strain TA 1537 in the pre-incubation assay at 5000µg/plate with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Was observed in all tester strains used in experiment I and II (with and without metabolic activation). In experiment I precipitation of the test item was found at concentrations of 316 µg/plate and higher (with and without metabolic activation), in experiment II precipitation of the test item was found at concentrations of 1000 µg/plate and higher (with and without metabolic activation).
ADDITIONAL INFORMATION ON CYTOTOXICITY: No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated with and without metabolic activation in experiment I and II, with the exception of a toxie effect observed in tester strain TA 1537 in experiment II at a concentration of 5000 µg/plate (with metabolic activation). The reduction in the number of revertants down to a mutation factor of 0.5 found in experiment II in tester strain E. coli WP2 uvrA at a concentration of 10.0 µg/plate (without metabolic activation) was regarded as not biologically relevant due to lack of a dose-response relationship. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the substance did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1